The New York Times reports that Federal prosecutors have issued a subpoena seeking information and all documents including transcripts of their testimony produced in litigation relating to three prominent Harvard researchers…

Read More

An early e-mail (dated 1999) states: "Dr. Biederman is not someone to jerk around.  He is a very proud national figure in child psych and has a very short fuse."

Read More

OHRP Investigation of experimental treatment for Acute Respiratory Distress Syndrome. ARDSNet studies: ARMA, FACCT, and ALVEOLI Table of Contents to Fax from OHRP page 1 Oct. 7, 2002 OHRP letter to: Ronald S. Newvbower, Ph.D(Mass. General Hospital), Lee E. Limbird, Ph.D. (Vanderbilt University), and Robert Kay, MD) (Cleveland Clinic Foundation) page 2 “OHRP continues to…

Read More

Japan Links 81 Deaths to new Lung Cancer Drug Thu, 5 Dec 2002 Now a days, the fate of a drug depends not so much on its efficacy and safety, but rather on the financial needs of the manufacturer and the company’s ability to round up an “independent” panel of experts to give the drug…

Read More

FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post Thu, 18 Nov 2004 The Washington Post examines FDA’s record of surveillance and the evidence is clear: since 1992 when Congress required drug companies to pay users fees to the FDA, the agency’s focus changed from safety concerns to business concerns. Curt…

Read More

NIH Under Fire: Longtime Favorite of Congress – Wash Post / WSJ Sun, 27 Jun 2004 Under fire from Congress with evidence of NIH staff engaging in secret outside contracts and consultancies, NIH Director, Dr. Elias Zerhouni, turned a corner. He acknowledged the problem at a hearing (June 22) of the House oversight subcommittee of…

Read More